I sat down with #CAI's VP Marketing and Consulting Services, David Shenberger and Chief Strategy Officer Alice Redmond to look back at 2022, and get some predictions for 2023
We discussed #consolidationofassets and pipelines, #ATMPS, #RegulatoryFrameworks, #AI #Pharma4.0, #ChatGPT, #pharmapricing, #outsourcing and a lot more.
I asked....
2022 ๐๐๐๐ฅ๐๐๐ญ๐ข๐จ๐ง๐ฌ
โข Can you give me a quick overview of CAI? 00:43
โข One word to describe 2022 and why? 01:49
โข What were some of CAI key achievements in 2022? 03:00
โข Have clients expectations changed since the pandemic? 04:19
โข Looking back at 2022 what challenges did you see the sector face, and developments stood out for you? 06:00
โข Does the growth of ATMPS changed how they work with clients? 09:07
โข Are there any areas you think the industry could improve? 10:36
2023 ๐
๐จ๐ซ๐๐๐๐ฌ๐ญ๐ฌ
โข What are your predictions for the #LifeSciences, #Pharma and #BioPharma in 2023? 12:06
โข What developments and trends do you expect to see/predict for #PharmaManufacturing? 16:55
โข What can we expect CAI in 2023? 17:44
โข Finally, what last thoughts would you like to leave viewers with for 2023? 20:45
๐ WATCH the interview here https://lnkd.in/eMWuGXmF
Feel free to leave any questions or comments for Alice or David below.
You can learn more about CAI at www.cagents.com